Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 9/20 | 0.51 |
| ▸ | PNP | P00491 | 4/20 | 0.48 |
| ▸ | TK1 | P04183 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | EDNRA | P25101 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | HBB | P68871 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | VCP | P55072 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL27719141 | 0.94 | PNP (0.49) | XDHPNPHPRT1 | |
| SCHEMBL986800 | 0.85 | XDH (0.60) | XDHPNPTK1MEN1KMT2A | |
| SCHEMBL15005119 | 0.84 | XDH (0.59) | XDHPNPTK1MEN1KMT2A | |
| SCHEMBL4426345 | 0.81 | XDH (0.54) | XDHPNPTK1MEN1KMT2A | |
| SCHEMBL4621403 | 0.76 | XDH (0.50) | XDHPNPTK1MEN1KMT2A | |
| SCHEMBL4857246 | 0.76 | XDH (0.46) | XDHPNPTK1MEN1KMT2A | |
| SCHEMBL1825531 | 0.76 | XDH (0.51) | XDHPNPTK1MEN1KMT2A | |
| SCHEMBL1065184 | 0.75 | ADORA2A (0.44) | — | |
| SCHEMBL1831279 | 0.75 | XDH (0.50) | XDHPNPTK1MEN1KMT2A | |
| SCHEMBL72147 | 0.75 | XDH (0.50) | XDHPNPTK1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117736984-A | Regulatory B cell producing interleukin-37 and preparation method and application thereof | 深圳大学 | 2024-03-22 | — | — | CN | claimed |
| CN-116549628-A | Preparation method of nano vaccine for enhancing organism anti-tumor immunity through targeting dendritic cells | 海南大学 | 2023-08-08 | — | — | CN | claimed |
| CN-112007170-B | Immune adjuvant functionalized metal organic framework material and preparation method and application thereof | 南方医科大学皮肤病医院（广东省皮肤病医院、广东省皮肤性病防治中心、中国麻风防治研究中心） | 2023-06-13 | — | — | CN | claimed |
| US-20230102739-A1 | DETECTION OF EPIGENETIC MODIFICATIONS | CAMBRIDGE EPIGENETIX LIMITED (GB) | 2023-03-30 | — | — | US | claimed |
| CN-114807153-A | Multiple CpG oligodeoxynucleotide with immune stimulation activity and application thereof | 南京吉盛澳玛生物医药有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-108472358-B | Nucleic acid derivatives with immunopotentiating activity | 盐野义制药株式会社 | 2022-06-24 | — | — | CN | claimed |
| EP-3838294-A1 | NEGATIVELY CHARGED NUCLEIC ACID COMPRISING COMPLEXES FOR IMMUNOSTIMULATION | CureVac AG (DE) | 2021-06-23 | — | — | EP | claimed |
| CN-112007170-A | Immunologic adjuvant functionalized metal organic framework material and preparation method and application thereof | 南方医科大学皮肤病医院（广东省皮肤病医院、广东省皮肤性病防治中心、中国麻风防治研究中心） | 2020-12-01 | — | — | CN | claimed |
| CN-110997935-A | Detection of epigenetic modifications | 剑桥表现遗传学有限公司 | 2020-04-10 | — | — | CN | claimed |
| EP-3625365-A2 | DETECTION OF EPIGENETIC MODIFICATIONS | Cambridge Epigenetix Limited (GB) | 2020-03-25 | — | — | EP | claimed |
| US-20170151204-A1 | USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-I-LIKE RECEPTOR LIGAND, OR A NOD-LIKE RECEPTOR LIGAND TO ENHANCE THE INNATE IMMUNE RESPONSE | UNIVERSITé LAVAL (CA) | 2017-06-01 | — | — | US | claimed |
| US-9382308-B2 | CD133 epitopes | CEDARS-SINAI MEDICAL CENTER (US) | 2016-07-05 | — | — | US | claimed |
| US-9068020-B2 | CD133 epitopes | CEDARS-SINAI MEDICAL CENTER (US) | 2015-06-30 | — | — | US | claimed |
| US-20150118183-A1 | NEGATIVELY CHARGED NUCLEIC ACID COMPRISING COMPLEXES FOR IMMUNOSTIMULATION | CUREVAC GMBH (DE) | 2015-04-30 | — | — | US | claimed |
| EP-2809354-A1 | NEGATIVELY CHARGED NUCLEIC ACID COMPRISING COMPLEXES FOR IMMUNOSTIMULATION | Curevac GmbH (DE) | 2014-12-10 | — | — | EP | claimed |
| US-20130236496-A1 | USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-I-LIKE RECEPTOR LIGAND, OR A NOD-LIKE RECEPTOR LIGAND TO ENHANCE THE INNATE IMMUNE RESPONSE | UNIVERSITE DE LAVAL (CA) | 2013-09-12 | — | — | US | claimed |
| WO-2013113502-A1 | NEGATIVELY CHARGED NUCLEIC ACID COMPRISING COMPLEXES FOR IMMUNOSTIMULATION | CUREVAC GMBH (DE) | 2013-08-08 | — | — | WO | claimed |
| US-20130183378-A1 | CD133 Epitopes | CEDARS-SINAI MEDICAL CENTER (US) | 2013-07-18 | — | — | US | claimed |
| WO-2012000082-A1 | USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-L-LIKE RECEPTOR LIGAND OR A NOD-LIKE RECEPTOR LIGAND TO ENHANCE THE INNATE IMMUNE RESPONSE | UNIVERSITé LAVAL (CA) | 2012-01-05 | — | — | WO | claimed |
| CN-1554359-A | Process for preparing cytosine suanine dinuleotide sequence molecule immunopotentiator | 广东省农业科学院农业生物技术研究所 | 2004-12-15 | — | — | CN | claimed |